首页> 外文期刊>The Journal of biological chemistry >Arginine and Glutamate-rich 1 (ARGLU1) Interacts with Mediator Subunit 1 (MED1) and Is Required for Estrogen Receptor-mediated Gene Transcription and Breast Cancer Cell Growth
【24h】

Arginine and Glutamate-rich 1 (ARGLU1) Interacts with Mediator Subunit 1 (MED1) and Is Required for Estrogen Receptor-mediated Gene Transcription and Breast Cancer Cell Growth

机译:富含精氨酸和富含谷氨酸的1(Arglu1)与介质亚单位1(Med1)相互作用,并且是雌激素受体介导的基因转录和乳腺癌细胞生长所必需的

获取原文
           

摘要

Estrogen receptor is a nuclear receptor superfamily member of transcriptional activators that regulate gene expression by recruiting diverese transcriptional coregulators. The Mediator complex is a central transcriptional coactivator complex that acts as a bridge between transcriptional activators and RNA polymerase II. MED1 (Mediator subunit 1) is the key Mediator subunit that directly interacts with estrogen receptor to mediate its functions both in vitro and in vivo. Interestingly, our previous biochemical analyses indicated that MED1 exists only in a subpopulation of the Mediator complex that is enriched with a number of distinct Mediator subunits and RNA polymerase II. Here, we report ARGLU1 as a MED1/Mediator-associated protein. We found that ARGLU1 (arginine and glutamate rich 1) not only colocalizes with MED1 in the nucleus, but also directly interacts with a far C-terminal region of MED1. Reporter assays indicate that ARGLU1 is able to cooperate with MED1 to regulate estrogen receptor-mediated gene transcription. Importantly, ARGLU1 is recruited, in a ligand-dependent manner, to endogenous estrogen receptor target gene promoters and is required for their expression. Furthermore, by ChIP-reChIP assay, we confirm that ARGLU1 and MED1 colocalize on the same estrogen receptor target gene promoter upon estrogen induction. Moreover, we found that depletion of ARGLU1 significantly impairs the growth, as well as anchorage-dependent and -independent colony formation of breast cancer cells. Taken together, these results establish ARGLU1 as a new MED1-interacting protein required for estrogen-dependent gene transcription and breast cancer cell growth.
机译:雌激素受体是通过募集分发剂转录核心剂来调节基因表达的转录活化剂的核受体超家族。介质复合物是中央转录共同膜复合物,其用作转录活化剂和RNA聚合酶II之间的桥。 Med1(介质亚基1)是直接与雌激素受体直接相互作用的关键介质亚基,以在体外和体内介导其功能。有趣的是,我们以前的生化分析表明Med1仅存在于富含介质复合物的亚级,其富含许多不同的介质亚基和RNA聚合酶II。在这里,我们将Arglu1报告为Med1 /介质相关蛋白。我们发现arglu1(精氨酸和富谷氨酸富甲酸盐1)不仅与核中的Med1分开,也直接与Med1的远的C末端区域相互作用。记者测定表明,arglu1能够与Med1配合以调节雌激素受体介导的基因转录。重要的是,以配体依赖性方式募集arglu1以与内源性雌激素受体靶基因启动子募集,并且是它们的表达所必需的。此外,通过芯片循环测定,我们确认在雌激素诱导时,arglu1和Med1在相同的雌激素受体靶基因启动子上分解在相同的雌激素受体靶基因启动子上。此外,我们发现arglu1的耗尽显着损害了乳腺癌细胞的锚固依赖性和依赖性菌落形成。总之,这些结果建立了arglu1作为雌激素依赖性基因转录和乳腺癌细胞生长所需的新Med1相互作用蛋白。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号